Trials / Completed
CompletedNCT00929981
A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
Medrol® In Contact Dermatitis: A Prospective Study To Assess The Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will be a prospective, non-interventional, single arm and open label study, in patients with contact dermatitis requiring systemic steroid therapy with a purpose to obtain the real life effectiveness and tolerability of Medrol in treating contact dermatitis in Indian patients. Patients with contact dermatitis who have been prescribed for Medrol will be enrolled into the study and will be followed up for the resolution of symptoms
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tablet Methylprednisolone (4 or 16 mg) | Oral Methylprednisolone tablets (4mg, 16mg) will be given as per locally approved prescribing information |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2009-06-30
- Last updated
- 2019-01-02
- Results posted
- 2011-12-26
Locations
4 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00929981. Inclusion in this directory is not an endorsement.